Ecolab to Webcast Annual Meeting on May 3, 2018
ST. PAUL, Minn.--(BUSINESS WIRE)-- Ecolab will host a live webcast of its annual meeting of stockholders to be held at Ecolab Global Headquarters, 1 Ecolab Place, St. Paul, Minn.
Details for the public webcast are as follows:
|
TIME: |
10:30 a.m. Eastern Time | |||
|
DATE: |
Thursday, May 3, 2018 | |||
|
DURATION: |
Approximately 30 minutes | |||
|
LOCATION: |
||||
|
ARCHIVE: |
A replay of the webcast will be available through May 10, 2018. | |||
To access the webcast, visit the Investor News and Events section of Ecolab’s website at www.ecolab.com/investor and click on the webcast details. Internet access and Windows Media Player or other compatible streaming media player are needed to access the webcast.
About EcolabA trusted partner at nearly three million customer locations, Ecolab (ECL) is the global leader in water, hygiene and energy technologies and services that protect people and vital resources. With annual sales of $14 billion and 48,000 associates, Ecolab delivers comprehensive solutions, data-driven insights and on-site service to promote safe food, maintain clean environments, optimize water and energy use, and improve operational efficiencies for customers in the food, healthcare, energy, hospitality and industrial markets in more than 170 countries around the world. For more Ecolab news and information, visit www.ecolab.com.
Follow us on Twitter @ecolab, Facebook at facebook.com/ecolab, LinkedIn at Ecolab or Instagram at Ecolab Inc.
(ECL-C)
View source version on businesswire.com: https://www.businesswire.com/news/home/20180425006506/en/
Ecolab Inc.
Michael Monahan, 651-250-2809
or
Andrew
Hedberg, 651-250-2185
Source: Ecolab Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Hilton Grand Vacations approves new $600M share repurchase plan
- 49th Parallel Wealth Management Closes Out a Summer of Cross-Border Innovation -- Free Tools, an Audiobook, and a New App, With a Hardcover Edition on the Way
- Merck and Moderna's melanoma drug combo beats Keytruda alone in trial
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share